Engineering the pancreatic niche: Mechanobiological insights into stem cell-derived β-cell therapy for diabetes mellitus
Mechanobiology · 27.01.2026 · 1
DOI: 10.1177/29780241261418480 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mechanobiology, online erschienen am 27.01.2026. Verfasst von Swaminadhan Dandapani und 1 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 273 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Soonchunhyang University Research Fund, the National Research Foundation of Korea funded by the Ministry of Science and ICT.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus remains a growing global health burden, yet advances in mechanobiology highlight a pivotal role for mechanical cues in regulating pancreatic β-cell function. This review summarizes evidence that the extracellular matrix (ECM) surrounding pancreatic islets is not merely structural support but a dynamic mechanosignaling platform integrating biochemical and physical stimuli to govern β-cell fate. In healthy tissue, a compliant ECM enriched in collagen IV and laminin supports optimal insulin secretion and glucose responsiveness. In contrast, obesity- and diabetes-associated fibrosis induces excessive ECM deposition, aberrant crosslinking, and pathological stiffening, disrupting mechanosensing, glucose signaling, and β-cell maturation. Mechanical forces are transmitted through integrin-mediated focal adhesions and FAK activation, triggering MAPK, PI3K–AKT, and Rho GTPase pathways that regulate cytoskeletal tension, transcriptional programming, and survival. Mechanosensitive Piezo1 channels convert membrane stretch into Ca 2+ influx, modulating insulin exocytosis, while the Hippo–YAP/TAZ axis interprets matrix stiffness to control β-cell proliferation and phenotypic stability. Chronic hyperglycemia further induces nuclear deformation and chromatin remodeling, impairing transcription factors such as PDX1 and accelerating β-cell dysfunction. These pathways intersect with inflammatory and oxidative stress signaling, driving apoptosis and progressive β-cell loss in type 2 diabetes. By reframing diabetes as a disorder of aberrant cell–matrix communication, this review highlights mechanobiology-guided strategies including stiffness-tunable matrices, viscoelastic hydrogels, and mechano-responsive scaffolds to restore a functional microenvironment. Targeting ECM remodeling, modulating Piezo1 activity, and fine-tuning YAP signaling, particularly with stem cell-derived β-cell replacement, offers a promising approach for restoring β-cell mass and achieving durable glycemic control.
Förderung
- the Soonchunhyang University Research Fund
- the National Research Foundation of Korea funded by the Ministry of Science and ICT
Zitieren
APA
Dandapani, S., & Hwang, Y. (2026). Engineering the pancreatic niche: Mechanobiological insights into stem cell-derived β-cell therapy for diabetes mellitus. Mechanobiology, 1. https://doi.org/10.1177/29780241261418480
Vancouver
Dandapani S, Hwang Y. Engineering the pancreatic niche: Mechanobiological insights into stem cell-derived β-cell therapy for diabetes mellitus. Mechanobiology. 2026;1. doi:10.1177/29780241261418480
BibTeX
@article{Dandapani2026,
author = {Dandapani, Swaminadhan and Hwang, Yongsung},
title = {Engineering the pancreatic niche: Mechanobiological insights into stem cell-derived β-cell therapy for diabetes mellitus},
journal = {Mechanobiology},
year = {2026},
volume = {1},
doi = {10.1177/29780241261418480}
}
EUVIMED